An Interview With Catherine Miller, PharmD, of Intellia Therapeutics on an Experimental Gene Editing Therapy for HAE

Rare Care Podcast
01/10/2025 13 min Temporada 1 Episodio 192
An Interview With Catherine Miller, PharmD, of Intellia Therapeutics on an Experimental Gene Editing Therapy for HAE

Listen "An Interview With Catherine Miller, PharmD, of Intellia Therapeutics on an Experimental Gene Editing Therapy for HAE"

Descargar episodio Ver en sitio original

Episode Synopsis

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Catherine Miller, PharmD, global medical affairs lead for hereditary angioedema (HAE) at Intellia Therapeutics, on an experimental gene editing therapy known as lonvo-Z.

More episodes of the podcast Rare Care Podcast

An Interview With Gabriela Romanow, Founder of Rare Vision, a Nonprofit That Helps Artists With Rare Neuroimmune Diseases 04/11/2025
An Interview With Lisa Shea, Director of Global Patient Advocacy and Engagement for Immunology at Johnson & Johnson 29/10/2025
An Interview With Dr. Nicole Lamanna, Leukemia Specialist at Columbia University Medical Center 22/10/2025
An Interview With Dr. May Lee Tjoa, Maternal and Fetal Immunology Expert at Johnson & Johnson 15/10/2025
An Interview With Dr. John Mascarenhas, Professor at New York's Icahn School of Medicine 10/10/2025
An Interview With Dr. Shoshana Revel-Vilk, Director of the Gaucher Unit at Israel's Shaare Zedek Medical Center 24/09/2025
An Interview With Nikki McIntosh, Founder of Rare Mamas and SMA Patient Advocate 16/09/2025
An Interview With Dr. Jennifer Brown, Director of the CLL Center at Dana-Farber Cancer Institute 08/09/2025
An Interview With Michio Hirano, MD, a Global Expert on Thymidine Kinase 2 Deficiency 03/09/2025
An Interview With Dr. Pradeep P.A. Mammen on Females With Duchenne Muscular Dystrophy 27/08/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA